38th Annual McEwan-Jones Lecture/Faculty Research Day: Dr. John DeLuca

Visiting Professor Speaker: 
John DeLuca, Ph.D.
Senior Vice President for Research
Kessler Foundation

Title: “Is it Time for MS Patients to Receive Cognitive Rehabilitation?”

Learning objectives:

• Participants will obtain a broad knowledge of cognitive impairments in persons with MS and its relationship to everyday functional abilities.
• Participants will become familiar with the behavioral data supporting cognitive rehabilitation in persons with MS
• Participants will become familiar with the brain imaging data associated with improvements in cognition with cognitive rehabilitation in persons with MS

It is now well established that many if not most persons with MS suffer from some degree of cognitive impairment. So, what clinicians need to know is what treatments are available and are they effective. This presentation will focus on the evidence supporting cognitive rehabilitation approaches to cognitive impairment in persons with MS. The talk will first broadly outline the nature of cognitive impairment in MS and its impact on functional activity. This will be followed by behavioral and brain imaging research supporting cognitive rehabilitation techniques in persons with MS. Data on pharmaceutical and exercise approaches will be briefly discussed. The talk will provide clinicians and researchers with practical information and guidance in the understanding, impact, and treatment options available for MS patients with cognitive impairment.

Featuring faculty speakers: (ascending order)
Atif Zafar (UHT: SMH)
Carmela Tartaglia (UHN)
Charles Kassardjian (UHT: SMH)
Dalia Rotstein (UHT: SMH)
Houman Khosravani (SHSC)
Jeff Wang (UHT: SMH)
Joanna Schaafsma (UHN)
Kristen Krysko (UHT: SMH)
Suvendrini Lena (WCH) 

DIVISION OF NEUROLOGY PUBLICATION AWARDEES

• Awardee (Category 1) Clinician Research Pub: Clinical epidemiology, clinical research, education and quality Improvement papers
• Awardee (Category 2) Basic Research Pub: Reports of research projects

This event is generously supported by McEwan-Jones Annual Neurological Lecture Fund and formal Division of Neurology Partnership Program with Alexion, Argenx, Biogen, EMD Serono, Lilly, Novartis, Paladin Pharma, Roche and UCB.